Explore how Mahamaya Lifesciences Ltd. performed during its IPO subscription phase, including investor participation, issue size, price band, and detailed steps on how to apply through ASBA or UPI.
The Mahamaya Lifesciences Ltd. IPO opened for subscription on November 11, 2025, attracting early investor interest in India’s expanding agrochemical and crop protection industry. The issue offers investors a chance to participate in the growing demand for sustainable agricultural inputs, including insecticides, herbicides, and bio-fertilisers.
Mahamaya Lifesciences Ltd. registered an overall subscription of 0.09×, with retail investors bidding 0.05× and non-institutional investors subscribing 0.26× on its opening day, marking a steady start to the issue.
On its opening day, the Mahamaya Lifesciences Ltd. IPO saw moderate participation from retail and non-institutional investors. The subscription data indicates early traction from smaller investors, while institutional participation is expected to build momentum in the coming days. The IPO remains open for subscription until November 13, 2025.
| Investor Category | Subscription (Times) |
|---|---|
| Retail Individual Investors (RII) |
0.05× |
| Non-Institutional Investors (NII) |
0.26× |
| Total |
0.09× |
This early response suggests cautious optimism in the market, with investors awaiting further clarity on institutional demand before the final day of bidding.
On the second day of bidding, Mahamaya Lifesciences Ltd. saw a gradual pickup in investor participation, particularly from institutional and non-institutional categories. The issue reached an overall subscription of 0.39x, reflecting growing engagement from market participants.
| Investor Category | Subscription (Times) |
|---|---|
| Qualified Institutional Buyers (QIBs) |
0.65x |
| Non-Institutional Investors (NIIs) |
0.46x |
| Retail Individual Investors (RIIs) |
0.19x |
| Total |
0.39x |
While retail subscriptions continued at a steady pace, institutional bids began to contribute more actively, hinting at improved traction as the IPO moved closer to its closing day.
The Mahamaya Lifesciences Ltd. IPO price band is set between ₹108 and ₹114 per share, with a face value of ₹10 per equity share. Investors can bid for a minimum of 1,200 shares (1 lot) and in multiples thereof.
At the upper price band, one lot amounts to an investment of ₹1,36,800, making the IPO an accessible entry point for retail investors and a scalable opportunity for HNIs exploring growth in India’s SME pharmaceutical space.
| Investor Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min/Max) |
1 |
1,200 |
₹1,36,800 |
| S-HNI (Min) |
2 |
2,400 |
₹2,73,600 |
| S-HNI (Max) |
10 |
12,000 |
₹13,68,000 |
| B-HNI (Min) |
11 |
13,200 |
₹15,04,800 |
This lot structure allows investors from various segments to participate according to their investment appetite. For detailed insights and live updates on allotment and listing, visit the Mahamaya Lifesciences IPO page on Bajaj Markets.
Here’s the complete IPO schedule outlining key events for investors — from subscription opening to listing on the exchange.
| Event | Date | Details |
|---|---|---|
| IPO Open Date |
November 11, 2025 |
IPO opens for bidding |
| IPO Close Date |
November 13, 2025 |
Final day for subscription |
| Basis of Allotment |
November 14, 2025 |
Share allotment finalisation |
| Initiation of Refunds |
November 17, 2025 |
Refunds begin for unallotted shares |
| Credit of Shares to Demat |
November 17, 2025 |
Shares credited to investors’ accounts |
| Listing Date (NSE SME) |
November 18, 2025 |
Expected debut on SME platform |
| UPI Mandate Cut-Off Time |
5 PM, November 13, 2025 |
Last time to confirm UPI mandate |
Note: These dates represent procedural milestones based on publicly available data and are intended for informational purposes only.
Investors can apply for the Mahamaya Lifesciences Ltd. IPO through ASBA (via Net Banking) or UPI (through broker platforms). Both are SEBI-approved, secure, and paperless methods of applying for IPOs.
Follow these simple steps to apply via your bank’s ASBA facility:
Log in to your internet banking account.
Go to the ‘Investments’ or ‘IPO Application’ section.
Select ‘Mahamaya Lifesciences Ltd. IPO’ from the available list.
Enter the number of lots and your bid price.
Confirm and submit your IPO application.
The bid amount will remain blocked in your account until allotment.
Once the shares are allotted, the amount will be debited, and shares will appear in your Demat account.
You can also apply through trading or investment apps that support UPI-based IPO applications.
Log in to your Demat account or trading account on your broker platform.
Navigate to the IPO section and select ‘Mahamaya Lifesciences Ltd. IPO’.
Enter your bid details, including lots and price.
Provide your UPI ID linked to your bank account.
Approve the mandate request in your UPI app (e.g., BHIM, Google Pay, PhonePe).
The funds will be blocked until allotment and debited only if shares are allotted.
Upon allotment, shares will be credited directly to your Demat account.
The information provided above is based on publicly available data from reliable financial news and market sources. Investors are advised to verify figures and consult financial experts before making investment decisions. Market conditions and subscription numbers are subject to change during the IPO window.
LiveMint — IPO News and Updates, https://www.livemint.com/market/ipo
Economic Times — IPO News: Latest IPO News, Upcoming IPO, https://economictimes.indiatimes.com/markets/ipo
Financial Express — IPO News, https://www.financialexpress.com/market/ipo-news/
NDTV Profit — IPOs, https://www.ndtvprofit.com/ipos
Business Today — IPO Corner: Latest IPO News & Analysis, https://www.businesstoday.in/markets/ipo-corner